American Video Teleconferencing Corp. (AVOT.PK) previously reported that it is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada. The property has been dormant since the 1960's when Hupon Mining and Exploration carried out surface work, stripping, trenching and a minor drill program of 445 feet contained in 11 drill holes. Some of the sample results from the trenching in 1962 showed 0.94% to 25% molybdenum averaging 5-10%. These values were obtained from assessment files in the Department of Mines in Quebec City.
The world's largest producers of molybdenum materials are the United States, China, Chile, Peru and Canada. This property is only one of several advanced stage properties AVOT has under consideration in the province of Quebec.
Molybdenum, is a Group 6 chemical element with the symbol Mo and atomic number 42. The free element, which is a silvery metal, has the sixth-highest melting point of any element. The ability of molybdenum to withstand extreme temperatures without significantly expanding or softening makes it useful in applications that involve intense heat, including the manufacture of aircraft parts, electrical contacts, industrial motors and filaments. Some other common uses for molybdenum are furnace applications, nuclear energy and missiles.
China said it will drastically limit exports of a group of minerals used in a host of consumer technology products, part of what the Obama administration sees as a broader strategy to unfairly help Chinese manufacturers.
The company believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. American Video Teleconferencing Corp. will aggressively continue to search world-wide for opportunities in Precious, Base and Rare Earths metal projects.
Rare Earth Minerals are used in cell phones, flat-screen televisions, hybrid cars and many other products.
Phillips-Van Heusen Corp. (NYSE:PVH) reported that the Company management will appear at the Cowen & Company 9th Annual Consumer Conference being held in New York City on Tuesday, January 11th at 8:00 AM. The live webcast as well as the replay, which will be available beginning one hour after the conference, may be accessed by logging onto www.pvh.com and going to the News Releases page under the Investor Relations tab.
Phillips-Van Heusen Corporation designs and markets branded dress shirts, neckwear, sportswear, footwear, and other related products worldwide. The company’s Calvin Klein Licensing segment licenses Calvin Klein Collection, ck Calvin Klein, and Calvin Klein brands for sportswear, jeanswear, underwear, fragrances, eyewear.
Power3 Medical Products, Inc. (PWRM.OB) plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
The acquisition of Rozetta-Cell is expected to be completed in February 2011.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
For more information about this company please visit http://www.power3medical.com
Dr Pepper Snapple Group, Inc. (NYSE:DPS) previously announced the expiration and settlement of its Dec. 1, 2010, cash tender offer (Tender Offer) for its 6.82% Senior Notes due 2018 (2018 Notes). The Tender Offer expired at 11:59 p.m., New York City time, on Dec. 29, 2010. Pursuant to the terms of the Tender Offer, the company purchased $475,732,000 aggregate principal amount of 2018 Notes that were validly tendered and not withdrawn in the Tender Offer. On Dec. 30, 2010, the company delivered to the Depository Trust Company $577,441,312.90 in cash as the aggregate consideration for the 2018 Notes purchased in the Tender Offer including accrued but unpaid interest.
Dr Pepper Snapple Group, Inc. operates as a brand owner, manufacturer, and distributor of non-alcoholic beverages in the United States, Canada, Mexico, and the Caribbean. It offers flavored carbonated soft drinks (CSDs) and non-carbonated beverages.
Texas Industries Inc. (NYSE:TXI) reported financial results for the quarter ended November 30, 2010. Results for the quarter were a net loss of $11.2 million or $.40 per share. Results for the quarter ended November 30, 2009 were a net loss of $3.7 million or $.13 per share and included after tax gains from the sale of emission credits of $2.1 million ($.08 per share).
Texas Industries, Inc., together with its subsidiaries, engages in the production and supply of heavy construction materials in the United States. The company operates in three segments: Cement, Aggregates, and Consumer Products.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has received from the company 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (AVOT.PK) for 12 months IR Services and 1,000,000 shares of (144) restricted common stock for its IT services.